P H Sugarbaker|P A Chretien - JoVE Visualize

Showing results (181-190 of 285) with videos related to

Pageof 29

Sort By:

Surgery|September 1, 1986

Preliminary report of a new treatment strategy for advanced pelvic malignancy: surgical resection and radiation therapy using afterloading catheters plus an inflatable displacement prosthesis in the treatment of advanced primary and recurrent rectal cancerH D Edington, S Hancock, F L Coe, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 27, 2001

Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operationH Yan, S R Pestieau, B M Shmookler, et al.

Cancer Treatment and Research|January 1, 1996

Safety constiderations in the use of intraoperative intraperitoneal chemotherapyS K White, A D Stephens, B Dowjat, et al.

The American Surgeon|November 3, 1998

Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancerW Yu, I Whang, A Averbach, et al.

Diseases of the Colon and Rectum|December 1, 1984

Prospective studies of laboratory and radiologic tests in the management of colon and rectal cancer patients: I. Selection of useful preoperative tests through an analysis of surgically occult metastasesF J Gianola, A Dwyer, A E Jones, et al.

British Journal of Cancer|August 1, 1987

Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2A M Eggermont, E P Steller, W Matthews, et al.

Cancer|September 1, 1993

Evaluation of computed tomography in patients with peritoneal carcinomatosisP Jacquet, J S Jelinek, M A Steves, et al.

Surgery|June 1, 1993

Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapyJ Esquivel, J Vidal-Jove, M A Steves, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1986

Recruitment of inflammatory cells to a tumor deposit potentiates the immunotherapeutic effects of interleukin-2E P Steller, A M Eggermont, W Matthews, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1987

Synergistic antitumor activity of cyclophosphamide and ABPP in the treatment of established and advanced tumors in murine tumor modelsA M Eggermont, P H Sugarbaker, R L Marquet, et al.

Pageof 29

Showing results (181-190 of 285) with videos related to

Sort By:

Pageof 29

Surgery|September 1, 1986

Preliminary report of a new treatment strategy for advanced pelvic malignancy: surgical resection and radiation therapy using afterloading catheters plus an inflatable displacement prosthesis in the treatment of advanced primary and recurrent rectal cancerH D Edington, S Hancock, F L Coe, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 27, 2001

Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operationH Yan, S R Pestieau, B M Shmookler, et al.

Cancer Treatment and Research|January 1, 1996

Safety constiderations in the use of intraoperative intraperitoneal chemotherapyS K White, A D Stephens, B Dowjat, et al.

The American Surgeon|November 3, 1998

Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancerW Yu, I Whang, A Averbach, et al.

Diseases of the Colon and Rectum|December 1, 1984

Prospective studies of laboratory and radiologic tests in the management of colon and rectal cancer patients: I. Selection of useful preoperative tests through an analysis of surgically occult metastasesF J Gianola, A Dwyer, A E Jones, et al.

British Journal of Cancer|August 1, 1987

Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2A M Eggermont, E P Steller, W Matthews, et al.

Cancer|September 1, 1993

Evaluation of computed tomography in patients with peritoneal carcinomatosisP Jacquet, J S Jelinek, M A Steves, et al.

Surgery|June 1, 1993

Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapyJ Esquivel, J Vidal-Jove, M A Steves, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1986

Recruitment of inflammatory cells to a tumor deposit potentiates the immunotherapeutic effects of interleukin-2E P Steller, A M Eggermont, W Matthews, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1987

Synergistic antitumor activity of cyclophosphamide and ABPP in the treatment of established and advanced tumors in murine tumor modelsA M Eggermont, P H Sugarbaker, R L Marquet, et al.

Pageof 29